Zelluna Immunotherapy
Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.
Total raised
€7.5M
€7,500,000
Funding rounds
2
Investors
1
distinct backers
Active since
2020-12
latest 2022-08
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 10y since founding
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-25 | Other | — | Takeda Ventures | View deal → |
| 2020-12-06 | Other | €7.5M | — | View deal → |
Investors
1Related news
- Zelluna Immunotherapy Receives Investment from Takeda Venturesfinsmes.com · 2022-08
- finsmes.com
Similar companies
same sector or country- Visma€3.0BNorway · Software
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Adevinta€1.9BNorway · Marketing
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech